08/28/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/19/2024
3:13 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:08 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:10 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:11 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:12 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:05 PM | Dyne Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
3:37 PM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
8:00 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4/A | |
06/24/2024
7:41 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
8:45 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:41 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
6:34 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
3:32 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:36 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
8:01 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:30 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/22/2024
6:59 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
5:00 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
3:24 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
6:37 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
8:03 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:04 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:05 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Act by Friday, August 16th, to collect this 22% dividend (Ad) For every $100 invested, you could collect up to $22 in dividends in the next 12 months.
But you must act by Monday, September 16th, to secure your first payment. Go here to get my full briefing about this ETF. |
05/17/2024
8:06 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
8:07 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:28 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:25 PM | Dyne Therapeutics (Filer)
| Form ARS | |
04/05/2024
3:15 PM | Dyne Therapeutics (Filer)
| Form DEF 14A | |
04/05/2024
3:20 PM | Dyne Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
8:06 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
8:07 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 3/A | |
04/04/2024
6:04 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
04/04/2024
3:22 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
3:24 PM | Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:24 PM | Cox John (Reporting)
Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
6:39 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
5:04 AM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:56 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:57 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:58 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
8:42 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:56 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:57 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:45 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:50 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:52 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:35 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:36 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:32 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:33 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:34 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:51 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:53 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:54 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:17 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:18 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:18 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:19 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
7:16 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
4:07 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:22 AM | Dyne Therapeutics (Filer)
| Form S-3ASR | |
03/05/2024
6:35 AM | Dyne Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
6:40 AM | Dyne Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
6:41 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:33 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Buried under the blight of America’s most dangerous city (Ad) In this video, I’ll show you how to get on the right side of this wealth transfer before it kicks into overdrive.  Go here to watch it now. |
03/01/2024
8:33 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
8:37 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
8:37 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
8:38 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:11 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:49 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:52 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
6:53 PM | Brumm Joshua T (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
6:13 PM | Atlas Venture Associates Opportunity I, L.P. (Reporting)
Atlas Venture Associates Opportunity I, LLC (Reporting)
Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund I, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
